Menu
Live News EQUITY L impact

Regentis Biomaterials 6-K filing

Regentis Biomaterials submits 6-K report to SEC. The report may contain material information about the company's operations.

RGTX

Filed: 2026-05-28 AccNo: 0001213900-26-062168 Size: 323 KB